Priortech Follow-Up: What an Access IPO Would Actually Change, and What Would Still Stay Trapped
Access's IPO filing moves Priortech's most important private asset onto a formal capital-markets track, but the 2025 report makes clear that value still has to pass through joint control at Access, Amitech, and capital notes before it reaches the parent. Even with Access operating from a much stronger base, this is not yet an automatic shortcut to parent-level value.
What The IPO Actually Changes
The main article argued that Priortech's core issue is not whether it owns good assets, but whether the value created below can actually move up. This follow-up isolates the Access IPO thread because it is one of the few developments that could genuinely change how the market reads the value layer underneath Priortech. But the key distinction matters from the start: the IPO changes the visibility and valuation layer first, not necessarily the cash layer.
On one level, this is a real event. On 30 September 2025 Access filed with the China Securities Regulatory Commission and the Shenzhen Stock Exchange for permission to publish a prospectus and proceed with an initial public offering, alongside a listing on ChiNext. Priortech's report describes that filing as the first formal step in the process. This is no longer just an IPO narrative. A process has started. But the same pages also spell out what still does not exist: as of the report date there was still no permit, no exchange approval, no known valuation, no known issuance structure or size, and the process in China could take more than a year.
The reason this thread still matters is that Access is now entering that path from a stronger operating base. In 2025 revenue rose to about RMB 2.089 billion from RMB 1.796 billion in 2024. Net profit climbed to about RMB 307.0 million from RMB 206.9 million, and operating cash flow increased to about RMB 511.4 million from RMB 440.7 million. So the market is not being asked to price a disconnected IPO story. It is being asked to price a company that reached the filing stage after roughly 16% revenue growth, roughly 48% net-profit growth, and roughly 16% operating cash flow growth.
That is also where the real analytical question starts. If the IPO advances, it could give Access a more visible market reference and eventually a more tangible monetization route. But all of that still sits at the Access layer. Priortech shareholders need to ask a different question: how value unlocked at Access ultimately becomes something accessible at the parent.
| Gate on the way up | What the IPO may improve | What it still does not solve on its own |
|---|---|---|
| Access layer | A more formal and visible capital-markets path | There is still no permit, no valuation, and no fixed timetable |
| Control layer | A private asset moves onto a public-market track | Joint control at Access remains in place |
| Amitech layer | A market event at Access could create an upstream trigger | There is still an intermediate layer with its own repayment and distribution rules |
| Priortech layer | The value story may become easier to read | That still does not mean cash automatically reaches parent shareholders |
Why The Route To Priortech Still Stays Long
The first obstacle is the control structure at Access. Under the agreements governing Access, its board has nine members: two appointed by Amitech, two by New Founder, one by an investment fund, and four independent directors. Ordinary decisions are taken by majority vote, but a broad list of financial, operational, and strategic decisions requires a special majority that includes at least one Amitech-appointed director and one New Founder-appointed director, and in some cases also an independent director. That is the core of this follow-up. Even if Access becomes public, Priortech through Amitech does not suddenly become the sole decision-maker over the asset.
The second obstacle is Amitech itself. Priortech owns 74.08% of Amitech, while the remaining stake is held by PC Fund. The Amitech investment agreement does not leave the cash path vague. Amitech's board has three members, two appointed by the majority holders and one by the minority holder as long as it owns at least 15% of the shares. The agreement also states that shareholder-loan repayments are to be made pari passu and pro rata based on the relative size of Priortech's and PC's combined equity investment and shareholder loans into Amitech, and that excess cash above Amitech's annual liquidity needs, after its commitments are met, is to be distributed within 120 days from the start of each calendar year. In other words, even if Access gains a clearer market value, the route upward still passes through an intermediate layer with its own defined traffic rules.
The third obstacle, and probably the most important one, is the capital-note structure. In the note on consolidated and associate holdings, Priortech shows that it funded Amitech with $103.1 million of capital notes. The same note says that most of PC's investment in Amitech, $24 million out of $25 million, was also provided as non-interest-bearing capital notes, in a structure similar to Priortech's own funding. Those notes are not repaid on an ordinary amortization schedule. They are returned only upon one of three events: a dividend from Access, a sale of Amitech's stake in Access, or a decision by Amitech's board.
That is exactly why the IPO is not a shortcut by itself. It may improve the odds of a visible valuation, and eventually perhaps a monetization path. But as long as repayment of the capital notes depends on distribution events, realization events, or board decisions, value still moves upward through a contractual sequence rather than an open pipe. The report adds one more important detail: because Amitech does not have an unconditional ability to avoid delivering cash, the capital note is presented as a financial liability, and any repayment is made pro rata according to the ownership percentages in Amitech. Put simply, even when cash starts moving, it will not necessarily move only toward Priortech.
The Cash Generated At Access Is Still Busy Inside Access
This is the point where an IPO thesis can become too easy. Access is generating cash, but 2025 does not look like a year in which cash simply piled up waiting to move upstream. Year-end cash stood at about RMB 317.4 million, up from about RMB 235.1 million a year earlier. That is a roughly 35% increase. But in the same year accounts receivable rose to about RMB 521.3 million, inventories to about RMB 313.6 million, and advances to suppliers to about RMB 48.8 million, versus only about RMB 13.9 million at the end of 2024.
That matters because it shows that the improvement at Access is not a story of idle cash simply accumulating. It is the story of a growing business where working capital expands and investment continues. Access's cash flow statement shows RMB 451.9 million of payments for fixed assets, intangible assets, and other long-term assets, against RMB 403.6 million in 2024. The supplementary cash-flow note sharpens the picture further: inventory absorbed about RMB 151.6 million, operating receivables absorbed another RMB 117.5 million, and only part of that was offset by roughly RMB 102.9 million of higher operating payables.
So even if the IPO progresses, two kinds of value still have to be separated. There is operating value, because Access ended 2025 larger, more profitable, and more cash generative than in 2024. But there is also value that is still not accessible, because the cash generated at Access first works inside Access, then has to move through Amitech, and only then, if the right event occurs, can it reach Priortech.
What Would Have To Happen For The IPO To Become Upstream Value
From here the story comes down to three practical tests. The first is regulatory: the process has to move from filing to permit and listing approval, otherwise the market is still dealing with an IPO thesis rather than an IPO event. The second is operational: Access has to preserve the revenue, profit, and cash-flow profile that justifies the public-market route, without letting working capital and investment absorb all of the economic improvement. The third, and the most important one for Priortech shareholders, is the upstream test: one of the contractual triggers that can return value through Amitech has to turn from legal language into a real event, whether through a dividend from Access, a sale of Amitech's Access stake, or an operative board decision at Amitech.
That is where the line sits between an attractive narrative and a clean thesis. An Access IPO could clearly change Priortech's value story, because it could make the group's most important private asset less opaque and easier to price. But it does not erase the fact that joint control, the Amitech layer, and the capital-note structure all still sit between Access and Priortech shareholders.
The thesis now: an Access IPO is a real re-rating thread, but not an automatic shortcut to parent cash. Until there is both regulatory progress and a clearer route for value to climb through Amitech, the story remains more about improving the valuation layer than breaking through the access-to-value bottleneck.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.